Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,809.18 +1,392.85 (+2.13%) CMC Crypto 200
1,350.62 -23.22 (-1.69%)
Ironwood Pharmaceuticals, Inc. (IRWD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.06B |
| Enterprise value | 1.62B |
| Trailing P/E | 11.42 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.51 |
| Price/book (mrq) | 2.59 |
| Enterprise value/revenue | 3.93 |
| Enterprise value/EBITDA | 5.54 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.57 |
| 52-week change 3 | -36.58% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 15.70 |
| 52-week low 3 | 6.21 |
| 50-day moving average 3 | 8.11 |
| 200-day moving average 3 | 10.12 |
Share statistics
| Avg vol (3-month) 3 | 4.46M |
| Avg vol (10-day) 3 | 3.12M |
| Shares outstanding 5 | 158.96M |
| Implied shares outstanding 6 | 158.96M |
| Float 8 | 140M |
| % held by insiders 1 | 1.73% |
| % held by institutions 1 | 111.06% |
| Shares short (30 Apr 2024) 4 | 20.08M |
| Short ratio (30 Apr 2024) 4 | 7.82 |
| Short % of float (30 Apr 2024) 4 | 24.57% |
| Short % of shares outstanding (30 Apr 2024) 4 | 12.63% |
| Shares short (prior month 28 Mar 2024) 4 | 21.95M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1194:1000 |
| Last split date 3 | 02 Apr 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -254.41% |
| Operating margin (ttm) | 15.30% |
Management effectiveness
| Return on assets (ttm) | 9.39% |
| Return on equity (ttm) | -574.72% |
Income statement
| Revenue (ttm) | 413.55M |
| Revenue per share (ttm) | 2.65 |
| Quarterly revenue growth (yoy) | -28.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 121.5M |
| Net income avi to common (ttm) | -1.05B |
| Diluted EPS (ttm) | -6.78 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 121.54M |
| Total cash per share (mrq) | 0.76 |
| Total debt (mrq) | 690.42M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.82 |
| Book value per share (mrq) | -2.08 |
Cash flow statement
| Operating cash flow (ttm) | 148.24M |
| Levered free cash flow (ttm) | 188.14M |
© 2024 Yahoo. All rights reserved.